232 related articles for article (PubMed ID: 24567069)
21. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
[TBL] [Abstract][Full Text] [Related]
22. Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue.
Hu C; Cong XD; Dai DZ; Zhang Y; Zhang GL; Dai Y
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):309-19. PubMed ID: 21267711
[TBL] [Abstract][Full Text] [Related]
23. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
Thongboonkerd V
Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
[TBL] [Abstract][Full Text] [Related]
24. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
25. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
26. The pre-proteinuric phase of diabetic nephropathy.
Christensen CK
Dan Med Bull; 1991 Apr; 38(2):145-59. PubMed ID: 2060322
[No Abstract] [Full Text] [Related]
27. Urinary proteomics for early diagnosis in diabetic nephropathy.
Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
29. Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook.
Dwyer JP; Lewis JB
Med Clin North Am; 2013 Jan; 97(1):53-8. PubMed ID: 23290729
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy.
Bermejo S; Soler MJ; Gimeno J; Barrios C; Rodríguez E; Mojal S; Pascual J
Nefrologia; 2016; 36(5):535-544. PubMed ID: 27523263
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
32. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
33. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
Darmayanti S; Lesmana R; Meiliana A; Abdulah R
Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
[TBL] [Abstract][Full Text] [Related]
34. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
[TBL] [Abstract][Full Text] [Related]
35. Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy.
Packham DK; Ivory SE; Reutens AT; Wolfe R; Rohde R; Lambers Heerspink H; Dwyer JP; Atkins RC; Lewis J;
Nephron Clin Pract; 2011; 118(4):c331-8. PubMed ID: 21293156
[TBL] [Abstract][Full Text] [Related]
36. Potential urine biomarkers for the diagnosis of prediabetes and early diabetic nephropathy based on ISN CKHDP program.
Gu D; Chen Y; Masucci M; Xiong C; Zou H; Holthofer H
Clin Nephrol; 2020; 93(1):129-133. PubMed ID: 32145759
[TBL] [Abstract][Full Text] [Related]
37. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
38. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
39. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
[TBL] [Abstract][Full Text] [Related]
40. Urinary proteomics in diabetes and CKD.
Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
